Together these results suggest that IL-1α, but not IL-1β, is responsible for activation of IL-1R1/MyD88 signaling and cytokine secretion triggered by cetuximab in HNSCC cells. This evidence concerns the gene MYD88 and head and neck squamous cell carcinoma.